Johnson & Johnson is looking to sell its Cerenovus stroke therapy business, according three unnamed people "with knowledge of ...

Johnson & Johnson has put its stroke care business up for sale, aiming for a valuation of more than $1bn, as part of its ...

Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion ...

The Dow Jones Industrial Average (\^DJI -0.50%) may be the most elite club in the stock market. The vaunted index holds only 30 blue chip stocks, making it a great source if you're ...

We recently published a list of 10 Best Stocks To Buy For Financial Stability. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best stocks ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

UBS analyst Amit Mehrotra upgraded Johnson Controls (JCI) to Buy from Neutral with a price target of $103, up from $90, implying about 20% upside from current levels. The firm is positive on the ...

Cancer is the second leading cause of death across the globe, second to cardiovascular disease. According to data by the American Cancer Society released in January 2023, the United States was ...

We recently published a list of 10 Best Environmental Stocks to Buy. In this article, we are going to take a look at where Johnson Controls International PLC (NYSE:JCI) stands against other best ...

Johnson & Johnson’s Consumer Health segment reported a revenue of $14.6 billion in the Full-Year 2021. It is projected that, following the separation, Kenvue will generate sales in over 100 ...

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...